MeSH tree: C12.050.351.500.852
Maintenance therapy with selinexor provides durable survival benefits for endometrial cancer with TP53 mutations, according to a study presented during the July 2023 session of the American Society for Clinical Oncology Plenary ...
Jul 28, 2023
0
73
To further motivate action to combat cervical cancer, BGI Genomics today released its State of Cervical Cancer Awareness Report. This report is released on World Self-Care Day, July 24, 2023, as the WHO notes that self-care—including ...
Jul 24, 2023
0
78
The findings of Griffith University research influenced the passing of a bill in Nigeria leading to a new law to ensure high school students receive compulsory education about breast, cervical and prostate cancers.
Jul 17, 2023
0
49
For women over the age of 65 who have never had a high-risk human papillomavirus (HPV) test, a "catch up" HPV screening intervention may improve cervical cancer prevention by detecting more cervical pre-cancer lesions as ...
Jul 6, 2023
0
55
The COVID pandemic has disrupted many areas of routine healthcare including, importantly, childhood vaccination.
Jul 5, 2023
0
47
While cancer mortality rates in the U.S. have decreased, cancer remains the leading cause of death among Hispanic individuals, who generally having lower cancer incidence compared to non-Hispanic white individuals.
Jun 29, 2023
0
27
Women with adenomyosis—a chronic condition that can cause pelvic pain and heavy menstrual bleeding—are at increased risk of infertility as well as problems in pregnancy and during birth, according to research presented at ...
Jun 28, 2023
0
37
Current evidence indicates Black women in the U.S. are at greater risk of developing advanced uterine cancer, also known as endometrial cancer, and of developing its more aggressive form—non-endometroid cancer—than white ...
Jun 26, 2023
0
38
For patients with adenomyosis, mifepristone is efficacious and has acceptable tolerability, according to a study published online June 12 in JAMA Network Open.
Jun 14, 2023
0
49
Experts are concerned about rapidly rising rates of HPV-related throat and mouth cancers, noting that if this trend continues, they could quickly be among the most common forms of cancer in adults between ages 45 and 65.
Jun 12, 2023
0
74
